This presentation was prepared by Dr. Viduranga Edirisinghe; upon request made by the board certified Consultant Cardiologist, Dr.(Mrs). Nimali Fernando, MD
This document discusses acute coronary syndrome (ACS) and non-ST-segment elevation acute coronary syndrome (NSTE-ACS). It defines unstable angina (UA) and non-ST elevation myocardial infarction (NSTEMI) and covers their clinical presentation, diagnostic criteria, laboratory investigation, and management. The key goals of diagnosis and treatment for NSTE-ACS patients are to recognize or exclude myocardial infarction, detect resting ischemia, and identify coronary artery obstruction. Treatment involves anti-ischemic, antithrombotic medications and consideration of coronary revascularization.
ACUTE CORONARY SYNDROME FOR CRITICAL CAREAbhinovKandur
The document defines acute coronary syndrome (ACS) as a group of diseases including unstable angina, myocardial infarction, and sudden cardiac death. ACS is classified into STEMI, NSTEMI, or unstable angina based on ECG and cardiac biomarker findings. The diagnosis of ACS involves taking a medical history, performing an ECG, and measuring cardiac biomarkers like troponin and CK-MB. Treatment involves pain relief medications, antiplatelet drugs, anticoagulants, and sometimes revascularization through procedures like angioplasty.
This document discusses STEMI (ST-elevation myocardial infarction). It defines STEMI and provides the universal definition involving cardiac biomarkers and ECG changes. It describes the five types of MI and lists the signs, symptoms, risk factors, diagnostic criteria involving ECG and cardiac enzymes. Treatment options including fibrinolytic therapy, PCI and medical therapies are summarized. Complications of STEMI both early and late are outlined.
Constrictive pericarditis is caused by scarring and thickening of the pericardium, restricting cardiac filling. It is diagnosed using echocardiography which shows septal bounce, exaggerated mitral inflow, and hepatic vein reversal. While similar to restrictive cardiomyopathy, constrictive pericarditis shows increased ventricular interaction and respiratory effects on cardiac physiology. Surgical pericardiectomy is usually required for treatment but is high risk, with post-op complications common. Long-term survival depends on the underlying cause of constriction.
Coronary artery disease (CAD) is a major cause of death in India. Atherosclerosis underlies most CAD cases. Unstable angina and NSTEMI are types of acute coronary syndrome (ACS) caused by a reduction in oxygen supply to the heart. The clinical presentation of ACS can include chest pain and other symptoms. Diagnosis involves ECG, cardiac biomarkers, and risk stratification. Treatment focuses on anticoagulation, antiplatelet therapy, and revascularization. Myocardial infarction (MI or heart attack) occurs when an atherosclerotic plaque ruptures completely blocking a coronary artery. This leads to necrosis of heart muscle cells. Diagnosis of MI requires specific ECG changes and elevated cardiac
Risk stratification in UA and NSTEMI: Why and How?cardiositeindia
This document discusses risk stratification in patients with unstable angina (UA) and non-ST-segment elevation myocardial infarction (NSTEMI). It summarizes three risk scores - the TIMI score, PURSUIT score, and GRACE score - and evaluates their ability to predict adverse cardiac outcomes at 30 days and 1 year. The study found that all three scores had fair to good predictive accuracy at 30 days, while the GRACE score was best at predicting outcomes at 1 year. Revascularization was found to provide greater benefit in higher risk patients as classified by these risk scores.
This document discusses acute coronary syndrome (ACS) and non-ST-segment elevation acute coronary syndrome (NSTE-ACS). It defines unstable angina (UA) and non-ST elevation myocardial infarction (NSTEMI) and covers their clinical presentation, diagnostic criteria, laboratory investigation, and management. The key goals of diagnosis and treatment for NSTE-ACS patients are to recognize or exclude myocardial infarction, detect resting ischemia, and identify coronary artery obstruction. Treatment involves anti-ischemic, antithrombotic medications and consideration of coronary revascularization.
ACUTE CORONARY SYNDROME FOR CRITICAL CAREAbhinovKandur
The document defines acute coronary syndrome (ACS) as a group of diseases including unstable angina, myocardial infarction, and sudden cardiac death. ACS is classified into STEMI, NSTEMI, or unstable angina based on ECG and cardiac biomarker findings. The diagnosis of ACS involves taking a medical history, performing an ECG, and measuring cardiac biomarkers like troponin and CK-MB. Treatment involves pain relief medications, antiplatelet drugs, anticoagulants, and sometimes revascularization through procedures like angioplasty.
This document discusses STEMI (ST-elevation myocardial infarction). It defines STEMI and provides the universal definition involving cardiac biomarkers and ECG changes. It describes the five types of MI and lists the signs, symptoms, risk factors, diagnostic criteria involving ECG and cardiac enzymes. Treatment options including fibrinolytic therapy, PCI and medical therapies are summarized. Complications of STEMI both early and late are outlined.
Constrictive pericarditis is caused by scarring and thickening of the pericardium, restricting cardiac filling. It is diagnosed using echocardiography which shows septal bounce, exaggerated mitral inflow, and hepatic vein reversal. While similar to restrictive cardiomyopathy, constrictive pericarditis shows increased ventricular interaction and respiratory effects on cardiac physiology. Surgical pericardiectomy is usually required for treatment but is high risk, with post-op complications common. Long-term survival depends on the underlying cause of constriction.
Coronary artery disease (CAD) is a major cause of death in India. Atherosclerosis underlies most CAD cases. Unstable angina and NSTEMI are types of acute coronary syndrome (ACS) caused by a reduction in oxygen supply to the heart. The clinical presentation of ACS can include chest pain and other symptoms. Diagnosis involves ECG, cardiac biomarkers, and risk stratification. Treatment focuses on anticoagulation, antiplatelet therapy, and revascularization. Myocardial infarction (MI or heart attack) occurs when an atherosclerotic plaque ruptures completely blocking a coronary artery. This leads to necrosis of heart muscle cells. Diagnosis of MI requires specific ECG changes and elevated cardiac
Risk stratification in UA and NSTEMI: Why and How?cardiositeindia
This document discusses risk stratification in patients with unstable angina (UA) and non-ST-segment elevation myocardial infarction (NSTEMI). It summarizes three risk scores - the TIMI score, PURSUIT score, and GRACE score - and evaluates their ability to predict adverse cardiac outcomes at 30 days and 1 year. The study found that all three scores had fair to good predictive accuracy at 30 days, while the GRACE score was best at predicting outcomes at 1 year. Revascularization was found to provide greater benefit in higher risk patients as classified by these risk scores.
Restrictive cardiomyopathy is characterized by impaired ventricular filling during diastole due to a primary decrease in ventricular compliance. The myocardium is partially infiltrated by noncontractile tissue or extracellular material, impairing the heart's ability to dilate. Causes include amyloidosis, sarcoidosis, and idiopathic restrictive cardiomyopathy. On morphology, the ventricles are normally or slightly enlarged while the cavities are not dilated. The myocardium is firm and noncompliant, and the atria show biatrial dilation. Patients experience signs and symptoms of congestive heart failure with prominent right-sided features.
This document provides an overview of acquired mitral valve disease, including:
1) It describes the anatomy of the mitral valve, including the annulus, leaflets, commissures, papillary muscles, and chordae tendineae.
2) It discusses mitral stenosis, including the pathophysiology of reduced orifice area leading to elevated left atrial and pulmonary pressures. Rheumatic fever is the most common cause in developed nations.
3) It outlines the clinical diagnosis of mitral stenosis through history, examination, ECG, echo, and hemodynamics. Severe untreated mitral stenosis progresses over 10 years from symptom onset to death.
The document discusses cardiogenic shock, outlining its definition, causes, pathophysiology, diagnosis and management, with a focus on shock complicating myocardial infarction. Cardiogenic shock occurs in 5-8% of patients hospitalized with ST-elevation myocardial infarction and has a high mortality rate of 70-80% despite emerging treatments. The document provides details on the hemodynamic parameters defining cardiogenic shock and reviews the various mechanisms that can lead to left or right ventricular failure and shock.
This document provides an overview of ischemic heart disease (IHD). IHD is caused by reduced blood flow to the heart muscle and includes conditions like angina and myocardial infarction. The main causes are atherosclerotic lesions in the coronary arteries leading to plaque buildup and blockages. Over time, plaques can rupture, causing blood clots that fully or partially block blood flow to the heart. This leads to insufficient oxygen delivery and cell death. The document outlines the pathogenesis and morphological changes that occur during angina and myocardial infarction as well as risk factors, diagnosis, and complications of IHD.
Aortic stenosis is a narrowing of the aortic valve that obstructs blood flow from the left ventricle to the aorta. It is most commonly caused by calcification and fibrosis of the aortic valve. Symptoms include dyspnea, exertional dizziness, and exertional angina as the left ventricle has to work harder to maintain adequate cardiac output against the increased resistance. On examination, the carotid pulse is weak and delayed while auscultation reveals a crescendo-decrescendo systolic murmur best heard at the right upper sternal border that radiates to the carotid arteries. Management involves prompt aortic valve replacement for symptomatic severe aortic stenosis.
Acute coronary syndrome (ACS) refers to conditions caused by reduced blood flow in the coronary arteries. This can be due to plaque buildup narrowing the arteries or plaque rupture leading to clot formation. ACS includes ST-elevation myocardial infarction (STEMI), non-ST-elevation myocardial infarction (NSTEMI), and unstable angina (UA). Patients present with chest pain and may have ECG changes or elevated cardiac biomarkers. Treatment involves oxygen, nitroglycerin, aspirin, and morphine (MONA) along with long-term therapies like antiplatelets, beta-blockers, statins, and ACE inhibitors to prevent future events.
The aortic valve has three cusps that open and close to regulate blood flow from the heart to the aorta. Aortic stenosis occurs when the valve opening narrows due to calcium buildup on the cusps. In the elderly, aortic stenosis is usually caused by age-related degeneration and calcification of the valve. Symptoms include chest pain, shortness of breath, and fainting. Diagnosis involves echocardiogram, Doppler ultrasound and cardiac catheterization. Treatment options include medications, balloon valvuloplasty, open-heart surgery to replace the valve, and newer transcatheter aortic valve replacement procedures for high-risk elderly patients.
Restrictive cardiomyopathy is characterized by stiff ventricles that do not fill properly, though systolic function is usually preserved initially. It can be caused by infiltrative diseases, fibrosis, or other processes that restrict ventricular filling. On echocardiogram, restrictive cardiomyopathy shows impaired ventricular filling and enlarged atria, while cardiac catheterization reveals elevated diastolic pressures and a distinctive "square root sign" pressure tracing. Treatment focuses on managing symptoms and underlying causes if identifiable, though prognosis is often poor without transplantation.
Mechanical thrombectomy is a minimally invasive procedure to remove blood clots from large brain vessels. It involves inserting a catheter through a small groin incision and using stent-like devices to remove clots causing acute ischemic strokes from large artery occlusion. It can benefit patients who are not candidates for or failed intravenous thrombolysis, especially if performed within 24 hours of symptom onset. Recovery depends on patient factors but may take weeks, with potential for improved outcomes over intravenous thrombolysis alone.
This case report describes a 14-year-old male who presented with episodes of palpitations, tachycardia, dyspnea and chest heaviness. His heart rate was found to be 190 bpm during episodes. He was diagnosed with reentrant supraventricular tachycardia. An ECG showed reentrant supraventricular tachycardia. He was treated with vasocardin and a beta blocker. He was discharged after a 24-hour ECG holter showed no further episodes while on medication.
Mitral stenosis is commonly caused by rheumatic heart disease which leads to inflammation and fusion of the mitral valve leaflets, reducing the mitral valve orifice area. Severe mitral stenosis, defined as a mitral valve area less than 1.0 cm2, can cause pulmonary hypertension, pulmonary edema, atrial fibrillation, and right heart failure as the heart tries to maintain sufficient cardiac output against the back pressure. Physical exam may reveal signs of pulmonary hypertension like a loud pulmonary component to S2, as well as a tapping apex, opening snap, and mid-diastolic rumble on cardiac auscultation. Echocardiography can determine the severity of mitral stenosis and assess
The document discusses various pericardial diseases including acute pericarditis, constrictive pericarditis, pericardial effusion, and cardiac tamponade. It provides details on the anatomy and functions of the pericardium, pathophysiology, clinical features, diagnostic tests, and management of these conditions. Key points include that pericardial diseases can present with non-specific symptoms, clinical suspicion is important for diagnosis, and treatment depends on underlying etiology and presence of hemodynamic compromise. Differentiating constrictive pericarditis from restrictive cardiomyopathy is important as treatment approaches differ significantly.
Aortic stenosis and aortic regurgitation aha american heart association new 2014Abdelrahman Al-daqqa
This document discusses aortic stenosis (AS) and aortic regurgitation (AR). It provides information on the prevalence and risk factors for each condition. For AS, it notes the increased prevalence with age. For AR, it discusses the varying prevalence with age and severity. The document also outlines the typical symptoms, physical exam findings, and treatment guidelines for AS and AR.
Acute coronary syndrome (ACS) occurs when a plaque in the coronary arteries ruptures or erodes, restricting blood flow. Plaque forms over time as LDL cholesterol builds up in artery walls due to risk factors like smoking, diabetes, and hypertension. The plaque contains an inflammatory necrotic core covered by a fibrous cap. Rupture occurs when the cap thins, exposing the core and triggering a clot. Medications treat ACS by lowering cholesterol and inflammation to stabilize plaques and prevent clots.
Ischemic heart disease is caused by an imbalance between blood supply and myocardial oxygen demand, most commonly due to atherosclerosis. It presents clinically as angina, myocardial infarction, or chronic heart failure. Myocardial infarction occurs when a coronary artery becomes occluded by a thrombus, causing transmural or subendocardial necrosis of the myocardium. Complications include arrhythmias, heart failure, ventricular rupture, or aneurysm formation depending on the size and location of the infarcted area. Prognosis depends primarily on infarct size, with larger transmural infarcts carrying a higher risk of complications.
Restrictive cardiomyopathy is characterized by impaired ventricular filling during diastole due to a primary decrease in ventricular compliance. The myocardium is partially infiltrated by noncontractile tissue or extracellular material, impairing the heart's ability to dilate. Causes include amyloidosis, sarcoidosis, and idiopathic restrictive cardiomyopathy. On morphology, the ventricles are normally or slightly enlarged while the cavities are not dilated. The myocardium is firm and noncompliant, and the atria show biatrial dilation. Patients experience signs and symptoms of congestive heart failure with prominent right-sided features.
This document provides an overview of acquired mitral valve disease, including:
1) It describes the anatomy of the mitral valve, including the annulus, leaflets, commissures, papillary muscles, and chordae tendineae.
2) It discusses mitral stenosis, including the pathophysiology of reduced orifice area leading to elevated left atrial and pulmonary pressures. Rheumatic fever is the most common cause in developed nations.
3) It outlines the clinical diagnosis of mitral stenosis through history, examination, ECG, echo, and hemodynamics. Severe untreated mitral stenosis progresses over 10 years from symptom onset to death.
The document discusses cardiogenic shock, outlining its definition, causes, pathophysiology, diagnosis and management, with a focus on shock complicating myocardial infarction. Cardiogenic shock occurs in 5-8% of patients hospitalized with ST-elevation myocardial infarction and has a high mortality rate of 70-80% despite emerging treatments. The document provides details on the hemodynamic parameters defining cardiogenic shock and reviews the various mechanisms that can lead to left or right ventricular failure and shock.
This document provides an overview of ischemic heart disease (IHD). IHD is caused by reduced blood flow to the heart muscle and includes conditions like angina and myocardial infarction. The main causes are atherosclerotic lesions in the coronary arteries leading to plaque buildup and blockages. Over time, plaques can rupture, causing blood clots that fully or partially block blood flow to the heart. This leads to insufficient oxygen delivery and cell death. The document outlines the pathogenesis and morphological changes that occur during angina and myocardial infarction as well as risk factors, diagnosis, and complications of IHD.
Aortic stenosis is a narrowing of the aortic valve that obstructs blood flow from the left ventricle to the aorta. It is most commonly caused by calcification and fibrosis of the aortic valve. Symptoms include dyspnea, exertional dizziness, and exertional angina as the left ventricle has to work harder to maintain adequate cardiac output against the increased resistance. On examination, the carotid pulse is weak and delayed while auscultation reveals a crescendo-decrescendo systolic murmur best heard at the right upper sternal border that radiates to the carotid arteries. Management involves prompt aortic valve replacement for symptomatic severe aortic stenosis.
Acute coronary syndrome (ACS) refers to conditions caused by reduced blood flow in the coronary arteries. This can be due to plaque buildup narrowing the arteries or plaque rupture leading to clot formation. ACS includes ST-elevation myocardial infarction (STEMI), non-ST-elevation myocardial infarction (NSTEMI), and unstable angina (UA). Patients present with chest pain and may have ECG changes or elevated cardiac biomarkers. Treatment involves oxygen, nitroglycerin, aspirin, and morphine (MONA) along with long-term therapies like antiplatelets, beta-blockers, statins, and ACE inhibitors to prevent future events.
The aortic valve has three cusps that open and close to regulate blood flow from the heart to the aorta. Aortic stenosis occurs when the valve opening narrows due to calcium buildup on the cusps. In the elderly, aortic stenosis is usually caused by age-related degeneration and calcification of the valve. Symptoms include chest pain, shortness of breath, and fainting. Diagnosis involves echocardiogram, Doppler ultrasound and cardiac catheterization. Treatment options include medications, balloon valvuloplasty, open-heart surgery to replace the valve, and newer transcatheter aortic valve replacement procedures for high-risk elderly patients.
Restrictive cardiomyopathy is characterized by stiff ventricles that do not fill properly, though systolic function is usually preserved initially. It can be caused by infiltrative diseases, fibrosis, or other processes that restrict ventricular filling. On echocardiogram, restrictive cardiomyopathy shows impaired ventricular filling and enlarged atria, while cardiac catheterization reveals elevated diastolic pressures and a distinctive "square root sign" pressure tracing. Treatment focuses on managing symptoms and underlying causes if identifiable, though prognosis is often poor without transplantation.
Mechanical thrombectomy is a minimally invasive procedure to remove blood clots from large brain vessels. It involves inserting a catheter through a small groin incision and using stent-like devices to remove clots causing acute ischemic strokes from large artery occlusion. It can benefit patients who are not candidates for or failed intravenous thrombolysis, especially if performed within 24 hours of symptom onset. Recovery depends on patient factors but may take weeks, with potential for improved outcomes over intravenous thrombolysis alone.
This case report describes a 14-year-old male who presented with episodes of palpitations, tachycardia, dyspnea and chest heaviness. His heart rate was found to be 190 bpm during episodes. He was diagnosed with reentrant supraventricular tachycardia. An ECG showed reentrant supraventricular tachycardia. He was treated with vasocardin and a beta blocker. He was discharged after a 24-hour ECG holter showed no further episodes while on medication.
Mitral stenosis is commonly caused by rheumatic heart disease which leads to inflammation and fusion of the mitral valve leaflets, reducing the mitral valve orifice area. Severe mitral stenosis, defined as a mitral valve area less than 1.0 cm2, can cause pulmonary hypertension, pulmonary edema, atrial fibrillation, and right heart failure as the heart tries to maintain sufficient cardiac output against the back pressure. Physical exam may reveal signs of pulmonary hypertension like a loud pulmonary component to S2, as well as a tapping apex, opening snap, and mid-diastolic rumble on cardiac auscultation. Echocardiography can determine the severity of mitral stenosis and assess
The document discusses various pericardial diseases including acute pericarditis, constrictive pericarditis, pericardial effusion, and cardiac tamponade. It provides details on the anatomy and functions of the pericardium, pathophysiology, clinical features, diagnostic tests, and management of these conditions. Key points include that pericardial diseases can present with non-specific symptoms, clinical suspicion is important for diagnosis, and treatment depends on underlying etiology and presence of hemodynamic compromise. Differentiating constrictive pericarditis from restrictive cardiomyopathy is important as treatment approaches differ significantly.
Aortic stenosis and aortic regurgitation aha american heart association new 2014Abdelrahman Al-daqqa
This document discusses aortic stenosis (AS) and aortic regurgitation (AR). It provides information on the prevalence and risk factors for each condition. For AS, it notes the increased prevalence with age. For AR, it discusses the varying prevalence with age and severity. The document also outlines the typical symptoms, physical exam findings, and treatment guidelines for AS and AR.
Acute coronary syndrome (ACS) occurs when a plaque in the coronary arteries ruptures or erodes, restricting blood flow. Plaque forms over time as LDL cholesterol builds up in artery walls due to risk factors like smoking, diabetes, and hypertension. The plaque contains an inflammatory necrotic core covered by a fibrous cap. Rupture occurs when the cap thins, exposing the core and triggering a clot. Medications treat ACS by lowering cholesterol and inflammation to stabilize plaques and prevent clots.
Ischemic heart disease is caused by an imbalance between blood supply and myocardial oxygen demand, most commonly due to atherosclerosis. It presents clinically as angina, myocardial infarction, or chronic heart failure. Myocardial infarction occurs when a coronary artery becomes occluded by a thrombus, causing transmural or subendocardial necrosis of the myocardium. Complications include arrhythmias, heart failure, ventricular rupture, or aneurysm formation depending on the size and location of the infarcted area. Prognosis depends primarily on infarct size, with larger transmural infarcts carrying a higher risk of complications.
Ischemic heart disease (IHD) is caused by an imbalance between the heart's blood supply and oxygen demand, usually due to atherosclerotic narrowing of the coronary arteries. This leads to myocardial ischemia and can result in angina, myocardial infarction (MI), or heart failure. MI occurs when ischemia is severe or prolonged enough to cause cardiac cell death. It is typically caused by coronary artery thrombosis due to atherosclerotic plaque rupture. MI can damage heart muscle and lead to complications like arrhythmias, heart failure, or cardiac rupture. Reperfusion through procedures like angioplasty aims to limit damage but can paradoxically worsen injury through reperfusion injury mechanisms.
Ischemic heart disease (IHD) is caused by reduced blood flow to the heart muscle and usually results from plaque buildup in the coronary arteries. This leads to not enough oxygen reaching the heart muscle. The main manifestations of IHD include angina pectoris (chest pain), myocardial infarction (heart attack), and sudden cardiac death. A heart attack occurs when a plaque ruptures and causes a blood clot that completely blocks blood flow, causing heart cell death. Reperfusion through procedures like angioplasty can limit damage but also cause additional injury. Complications from a heart attack include heart failure, arrhythmias, and cardiac rupture.
1. The document discusses atherosclerosis and ischemic heart disease. Atherosclerosis is a disease of large and medium arteries characterized by plaque buildup within the artery wall.
2. Risk factors for atherosclerosis include age, gender, family history, hyperlipidemia, hypertension, smoking, and diabetes. Grossly, plaques appear white to yellow and firm or soft. Microscopically, plaques contain macrophages, foam cells, cholesterol, and calcium.
3. Ischemic heart disease is caused by an imbalance between myocardial oxygen supply and demand. Myocardial infarction results from coronary artery occlusion and causes heart muscle cell death. On gross exam, infarcts appear yellow or hemorrhagic
1. A myocardial infarction occurs when blood flow to the heart is blocked, damaging heart muscle.
2. It is caused most often by atherosclerosis and plaque buildup that obstruct coronary arteries.
3. Symptoms include chest pain and other signs of reduced blood supply to the heart. Diagnosis is based on symptoms, electrocardiogram changes, and blood tests showing cardiac enzyme levels.
This document provides information about myocardial infarction including:
- Myocardial infarction is caused by interruption of blood supply to the heart muscle, usually due to blockage of a coronary artery.
- Risk factors that can lead to coronary artery blockage include hypertension, hyperlipidemia, diabetes, and smoking.
- A thrombus or embolism in a coronary artery cuts off the blood supply, causing cell death in the affected heart muscle area.
- The location and size of the infarction depends on which coronary artery is blocked. Transmural infarcts that penetrate the full heart wall thickness are more likely to cause complications than smaller subendocardial infarcts.
This document discusses the pathogenesis of atherosclerosis. It begins with a brief history of atherosclerosis and then discusses the structure of the normal artery and endothelial cells. It describes the response to injury hypothesis for the initiation and progression of atherosclerotic lesions. It discusses complications of atherosclerosis including plaque rupture and thrombosis. It concludes by discussing risk factors for atherosclerosis such as smoking, hypertension, hyperlipidemia, and metabolic syndrome.
1. An aneurysm is an abnormal dilation of a blood vessel that can be congenital or acquired due to weakening of the vessel wall.
2. Aneurysms are classified based on composition, shape, location, and pathogenetic mechanism. The most common type is atherosclerotic aneurysms, which often affect the abdominal aorta.
3. Complications of aneurysms include rupture, which can lead to fatal hemorrhaging, as well as compression of surrounding structures. timely diagnosis and treatment are important to prevent such complications.
Myocardial infarction, or a heart attack, occurs when blood flow to the heart is blocked, usually by a clot, damaging heart muscle. It can cause chest pain and is diagnosed through electrocardiograms, cardiac enzyme levels, and other tests. Over time, the damaged heart muscle is replaced with scar tissue through a healing process. Complications can include arrhythmias, heart failure, blood clots, or rupture of the heart muscle. Treatment involves lifestyle changes, medications, or procedures like stenting or bypass surgery to restore blood flow.
1. Myocardial infarction occurs when blood flow to the heart is blocked, causing death of heart muscle cells.
2. The degree of heart damage depends on the size of the blocked artery and amount of heart tissue affected.
3. There are two main types - ST-elevation MI where the full thickness of heart muscle is damaged, and non-ST-elevation MI where the inner layer is most affected.
1. Myocardial infarction occurs when blood flow to the heart is blocked, causing death of heart muscle cells. This can permanently damage the heart and disrupt its function.
2. Symptoms of a heart attack include chest pain or discomfort, shortness of breath, nausea, and feeling weak. Diagnosis is based on elevated cardiac troponin levels, ECG changes, and symptoms consistent with heart attack.
3. Left untreated, a heart attack can lead to heart failure, arrhythmias, heart rupture or cardiac arrest. Prompt treatment is crucial to reduce damage to the heart.
Atherosclerosis is a disease where plaque builds up inside arteries. It is a chronic inflammatory response causing a build-up of fat, cholesterol, and other substances in the arteries. This build-up is called atheroma or plaque. Common sites of atherosclerosis are the abdominal aorta, coronary arteries, and carotid arteries. Risk factors include high LDL cholesterol and low HDL cholesterol. The current hypothesis is that it is initiated by endothelial dysfunction allowing inflammation and migration of cells into the artery wall where they proliferate and accumulate lipids over time, forming plaque. If plaque ruptures, it can cause heart attack or stroke by blocking blood flow.
Atherosclerosis is a disease where plaque builds up inside arteries. It is a chronic inflammatory response causing a build-up of fat, cholesterol, and other substances in the arteries. This build-up is called atheroma or plaque. Common sites of atherosclerosis are the abdominal aorta, coronary arteries, and carotid arteries. Risk factors include high LDL cholesterol and low HDL cholesterol. The current hypothesis is that it is initiated by endothelial dysfunction allowing inflammation and migration of cells into the artery wall where they proliferate and accumulate lipids over time, forming plaque. If plaque ruptures, it can cause heart attack or stroke by blocking blood flow.
Myocardial infarction occurs when a coronary artery becomes blocked, interrupting blood flow to heart muscle. This causes damage and permanent loss of contraction in that portion of the heart. Over time, the affected area evolves from pallor to yellowing to fibrosis as dead heart cells are removed and replaced by scar tissue. Microscopically, early signs include wavy fibers at the border and loss of striations within infarcted regions. Complications can include arrhythmias, heart failure, mural thrombi, rupture and aneurysm formation depending on the size and location of the infarct. Examination of autopsy specimens involves analysis of coronary arteries and dissection of the heart to identify infarct location, extent and healing stage
This document discusses cerebrovascular diseases and provides details on various types:
1. It describes cerebrovascular disease as any abnormality of the brain caused by blood vessels, including thrombosis, embolism, and hemorrhage.
2. Stroke is defined as a sudden neurological deficit due to a vascular impairment, which is a common cause of death in the US.
3. Details are given on global cerebral ischemia from reduced blood flow and focal ischemia from localized vessel obstruction.
This document provides an overview of ischemic heart disease. It defines ischemic heart disease as a set of clinical conditions caused by a sudden reduction in blood flow to the heart. The main types discussed are angina pectoris, NSTEMI, and STEMI. The document discusses the pathogenesis of atherosclerosis and myocardial injury. It also covers the clinical presentation, diagnosis, and complications of stable angina, unstable angina, NSTEMI, STEMI, and ischemic reperfusion injury. Chronic ischemic heart disease and various cardiac biomarkers are also summarized.
1) Stroke is a leading cause of death and disability worldwide, with the majority caused by ischemia and hemorrhage. Intracerebral hemorrhage accounts for 20% of strokes and has a high mortality rate of 62% at 1 year.
2) Intracerebral hemorrhages most commonly occur in the cerebral lobes, basal ganglia, thalamus, brain stem, or cerebellum from the rupture of small blood vessels damaged by hypertension or amyloid angiopathy.
3) Patients receiving oral anticoagulation have a 7-10 fold increased risk of intracerebral hemorrhage compared to spontaneous hemorrhage. Hematoma expansion occurs for a longer period of time
Cardiomyopathies are a group of myocardial dysfunctions where the primary defect is within the myocardium itself and is not due to other causes like increased blood pressure, coronary artery disease, etc. There are several types of cardiomyopathies including dilated cardiomyopathy, hypertrophic cardiomyopathy, restrictive cardiomyopathy, and others. Dilated cardiomyopathy is the most common type, accounting for up to 90% of cases. It is characterized by progressive cardiac dilation and impaired contractility of the myocardium leading to systolic heart failure. Diagnosis involves tests like echocardiography, electrocardiography, cardiac catheterization and endomyocardial biopsy. Treatment focuses on reducing preload on the heart through medications like A
Similar to Pathogenesis of Acute Coronary Syndromes (20)
2. ACSs
• May result from new superimposed
thrombosis on a pre-existing ("fixed")
atherosclerotic occlusion and/or vasospasm of
one or more coronary arteries.
3. Role of Acute Plaque Changes
• In most patients, unstable angina, infarction,
and many cases of SCD all occur because of
abrupt plaque change followed by thrombosis.
• Hence the term acute coronary syndrome.
4. Acute Plaque Changes
Highly thrombogenic
plaque constituents
Rupture, fissuring, or
Exposing
ulceration
Underlying
subendothelial
basement membrane
Acute Coronary
Syndromes
Worsening of the
luminal occlusion
Hemorrhage into the Expansion of plaque
core of plaques volume
Plaque rupture
5.
6. Events that trigger the abrupt plaque
changes
• Rupture reflects the inability of a plaque to
withstand mechanical stresses.
• Triggers may be intrinsic or extrinsic
Intrinsic factors Extrinsic factors
• Large atheromatous • Adrenergic stimulation
core • Intense emotional stress
• Thickness of the fibrous
cap
7. Integrity of the Plaque
Fibrous caps are continuously remodeling
collagen collagen
synthesis degradation
Collagen produced by smooth muscle cells
Collagen degraded by the action of metalloproteinases (macrophages)
8. Role of Inflammation
• Inflammation plays an essential role at all
stages of atherosclerosis
• What’s the contribution of Inflammation to
acute coronary syndromes…?
Breakdown of Plaque
Neutrophil Release of
Inflammation collagen in the destabilization &
infiltration metalloproteinases
fibrous cap rupture
9. Role of Thrombus
• Formation of a thrombus on a disrupted
atherosclerotic plaque
• Significant rapid stenosis
• Complete occlusion of the coronary arteries
• Mural thrombus in a coronary artery can also
embolize
• Small fragments of thrombotic material
• Small infarcts
10. Acute Myocardial Infarction
• Ischemic necrosis of a part of the myocardium
• In a typical MI,
A sudden disruption of an atheromatous plaque
Platelets adhere, aggregate, become activated
Release potent secondary aggregators(thromboxane A2, adenosine diphosphate, and serotonin)
Other mediators activate the extrinsic pathway of coagulation
Vasospasm (platelet aggregation and mediator release)
Within minutes the thrombus can evolve to completely occlude the coronary lumen of the coronary vessel
11. Acute Myocardial Infarction
Electrical instability of the Arrhythmias (ventricular
myocardium fibrillation)
Ischemia Death of myocardium
Or a fatal mechanical failure
Reduction in the contractility of
the myocardium
Reduction in the ejection fraction
& increase in end systolic volume
& pressure (Heart failure)
12. • Irreversible injury of ischemic myocytes first
occurs in the subendocardial zone (STEMI)
• With more prolonged ischemia
• Involve progressively more of the transmural
thickness (NSTEMI)